Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2022-08-25 Earnings Release
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare semi-annual report – strategic measures lead to strong increase in external revenue and increased operational capacity
Earnings Release Classification · 1% confidence The document is titled 'Lifecare semi-annual report' and presents strong financial results for the first half-year (1H 2022), including revenue figures and operational achievements. This strongly suggests it is a comprehensive report for a period shorter than a year, fitting the definition of an Interim/Quarterly Report (IR). However, the text explicitly states: 'Lifecare’s semi-annual report is available for downloading here: [link]' and announces a webcast presentation of these results. According to Rule #2 (The 'MENU VS MEAL' Rule), if the document is short (2401 chars) and announces the availability of the full report, it should be classified as a Report Publication Announcement (RPA) rather than the report itself (IR). The document serves primarily to announce the publication of the semi-annual report and the associated earnings call/presentation. H1 2022
2022-08-25 English
Lifecare innovations categorised by EU Innovation Radar as “Market Ready” and among top 14 % in terms of “Market Creation Potential” - Lifecare newsletter August 2022
Regulatory Filings Classification · 1% confidence The document is a short announcement dated August 8, 2022, detailing positive news regarding the company's technology being categorized as 'Market Ready' by the EU Innovation Radar. It provides key highlights about project involvement and links to a full newsletter. Given its brevity (2387 characters) and the nature of providing an update/highlight that directs the reader elsewhere for more detail (linking to the newsletter), it fits the description of an announcement rather than a comprehensive report (like 10-K or IR). Since it is not a specific announcement type like Director's Dealing (DIRS), Dividend (DIV), or Earnings Release (ER), and it is a general update about company progress and news, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory/news announcements that don't fit other specific codes.
2022-08-08 English
Subscriptions by primary insiders and employees under Lifecare Employee Share Purchase Program - Registration of new share capital
Share Issue/Capital Change Classification · 1% confidence The document explicitly discusses the registration of a share capital increase following an Employee Share Purchase Program subscription. Key phrases include 'Registration of new share capital', 'share capital increase has now been registered', and the final updated share capital figures. This directly relates to changes in the company's capital structure through the issuance of new shares, which aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA). Although it involves insider subscriptions, the primary focus and final action reported is the capital registration, not just the insider dealing (DIRS) or a general announcement (RNS). The document length is short (1474 chars), but it reports the completion of the capital change, not just the announcement of a report.
2022-07-26 English
Lifecare Employee Share Purchase Program – Subscriptions by Primary Insiders - Increase of share capital
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces an 'Increase of share capital' resulting from an Employee Share Purchase Program subscription. It details the number of shares issued (124,719), the resulting total outstanding shares (99,865,742), and the updated total share capital. This directly relates to changes in the company's capital structure due to new share issuance. This fits the definition of 'Share Issue/Capital Change' (SHA). It is not a general regulatory filing (RNS) because it is highly specific to a capital event, nor is it a Director's Dealing (DIRS) as it concerns an employee program resulting in a capital increase, not just insider trading disclosure.
2022-07-15 English
Lifecare Newsletter July
Report Publication Announcement Classification · 1% confidence The document is titled 'Lifecare Newsletter July' and is very short (924 characters). It summarizes recent company activities (milestones achieved, clinical study start) and directs the reader to an external link for more information. It concludes with a standard stock exchange announcement footer. This structure strongly suggests an announcement about the availability of a newsletter or update, rather than the full report itself. Since 'Newsletter' does not fit a specific category like ER, IR, or 10-K, and it is an announcement regarding published information, the most appropriate classification based on the provided definitions is Report Publication Announcement (RPA), as it announces the publication of the July newsletter/update.
2022-07-04 English
Lifecare har startet klinisk test av verdens minste glukosemåler for mennesker med diabetes
Regulatory Filings Classification · 1% confidence The document is a press release dated June 23, 2022, announcing the start of clinical trials for a new glucose monitoring sensor ('Sencell'). It details milestones, expected progress, background on the technology, and market context. This type of announcement, focusing on operational progress, product development milestones, and market potential, is characteristic of an Investor Presentation (IP) or a general corporate update. Since it is a detailed update on development progress and strategy, 'Investor Presentation' (IP) is the most fitting category, as it functions as a detailed update for investors beyond a simple earnings release (ER) or a brief regulatory filing (RNS). It is not a formal regulatory report like a 10-K or IR.
2022-06-23 Norwegian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.